BioCentury | Feb 5, 2021
Management Tracks

Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair

...business development and strategy and investor relations.Prior to Merck, Davis had a 10-year tenure at Baxter International...
BioCentury | Oct 26, 2020
Deals

Bayer’s $2B deal for AskBio follows biotech’s decision to bet on its own pipeline

...pharmas. Pfizer acquired Bamboo in 2016, while Baxter International...
BioCentury | Mar 19, 2020
Emerging Company Profile

OncoOne: targeting oxidized MIF for solid tumors

...tumor specificity.” The target was first identified as a tumor antigen by a team of Baxter International...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics Inc. and Prism Pharmaceuticals Inc., which Baxter International...
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Laboratories; Brent Saunders, chairman and CEO, Allergan plc; José (Joe) Almeida, chairman, president and CEO, Baxter International...
...Companies and Institutions Mentioned Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Baxter International...
...Inc. (NASDAQ:OVID), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Baxter International...
BioCentury | Apr 12, 2019
Finance

AskBio answers investors’ call

...hemophilia company Chatham Therapeutics LLC. Pfizer acquired Bamboo in 2016. Following a 2014 deal with Baxter International...
BioCentury | Nov 8, 2018
Product R&D

JLABS seeks lung cancer solutions in Shanghai

...job business development experience in Asia through prior positions at Aeras Global TB Vaccine Foundation, Baxter International...
...significant opportunities for innovation. Companies and Institutions Mentioned Aeras Global TB Vaccine Foundation, Rockville, Md. Baxter International...
BioCentury | Sep 28, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...
BioCentury | Sep 20, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...
BioCentury | Aug 4, 2018
Finance

Functions of formulation

...Helen Torley told BioCentury that at the time of Halozyme’s first deals with Roche and Baxter International...
...after ViroPharma Inc. was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG) in 2014; (C) In 2015, Baxter International...
...ViroPharma Inc. (B) 1 Inflammation Subcutaneous Cinryze (C1 esterase inhibitor) $9 $74 $83 10% 05/11/11 Baxter International...
Items per page:
1 - 10 of 708
BioCentury | Feb 5, 2021
Management Tracks

Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair

...business development and strategy and investor relations.Prior to Merck, Davis had a 10-year tenure at Baxter International...
BioCentury | Oct 26, 2020
Deals

Bayer’s $2B deal for AskBio follows biotech’s decision to bet on its own pipeline

...pharmas. Pfizer acquired Bamboo in 2016, while Baxter International...
BioCentury | Mar 19, 2020
Emerging Company Profile

OncoOne: targeting oxidized MIF for solid tumors

...tumor specificity.” The target was first identified as a tumor antigen by a team of Baxter International...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics Inc. and Prism Pharmaceuticals Inc., which Baxter International...
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Laboratories; Brent Saunders, chairman and CEO, Allergan plc; José (Joe) Almeida, chairman, president and CEO, Baxter International...
...Companies and Institutions Mentioned Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Baxter International...
...Inc. (NASDAQ:OVID), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Baxter International...
BioCentury | Apr 12, 2019
Finance

AskBio answers investors’ call

...hemophilia company Chatham Therapeutics LLC. Pfizer acquired Bamboo in 2016. Following a 2014 deal with Baxter International...
BioCentury | Nov 8, 2018
Product R&D

JLABS seeks lung cancer solutions in Shanghai

...job business development experience in Asia through prior positions at Aeras Global TB Vaccine Foundation, Baxter International...
...significant opportunities for innovation. Companies and Institutions Mentioned Aeras Global TB Vaccine Foundation, Rockville, Md. Baxter International...
BioCentury | Sep 28, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...
BioCentury | Sep 20, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International...
BioCentury | Aug 4, 2018
Finance

Functions of formulation

...Helen Torley told BioCentury that at the time of Halozyme’s first deals with Roche and Baxter International...
...after ViroPharma Inc. was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG) in 2014; (C) In 2015, Baxter International...
...ViroPharma Inc. (B) 1 Inflammation Subcutaneous Cinryze (C1 esterase inhibitor) $9 $74 $83 10% 05/11/11 Baxter International...
Items per page:
1 - 10 of 708